The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo

Materials Science and Engineering C

Volumn 33, Issue 8, 2013, Pages 4802-4808

  Wang, Ping ^a   Zhang, Libin ^a   Peng, Hao ^a   Li, Yongwu ^a   Xiong, Jian ^a   Xu, Zheyuan ^a  

^a FIRST PEOPLE S HOSPITAL OF YUNNAN PROVINCE   (China)

Author keywords

A549; Lung cancer; SLN curcumin; Tumor inhibition; TUNEL

Indexed keywords

BIOCHEMISTRY; CELL DEATH; DISEASES; DRUG PRODUCTS; EFFICIENCY; MEDICAL APPLICATIONS; NANOPARTICLES; SOL-GEL PROCESS; SOL-GELS; TUMORS;

A549; CURCUMIN; LUNG CANCER; TUMOR INHIBITION; TUNEL;

BIOLOGICAL ORGANS;

ANTINEOPLASTIC AGENT; CURCUMIN; DRUG CARRIER; KI 67 ANTIGEN; LIPID; NANOPARTICLE;

ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CARCINOMA, NON-SMALL-CELL LUNG; CHEMISTRY; DRUG EFFECTS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; TOXICITY; TUMOR CELL LINE; XENOGRAFT; A549; ARTICLE; CANCER INHIBITION; DRUG EFFECT; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG TUMOR; NICK END LABELING; SLN-CURCUMIN;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CURCUMIN; DRUG CARRIERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIPIDS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; TRANSPLANTATION, HETEROLOGOUS;

A549; LUNG CANCER; SLN-CURCUMIN; TUMOR INHIBITION; TUNEL;

EID: 84885181617     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2013.07.047     Document Type: Article

References (29)

1. K. Raparia, C. Villa, M.M. Decamp, J.D. Patel, M.P. Mehta, Molecular profiling in non-small cell lung cancer: a step toward personalized medicine, Arch. Pathol. Lab. Med. 137 (2013) 481-491.
2. P.M. Green, S. Guerrier-Adams, P.O. Okunji, D. Schiavone, J.E. Smith, African American health disparities in lung cancer, Clin. J. Oncol. Nurs. 17 (2013) 180-186.
3. S.C. Gupta, G. Kismali, B.B. Aggarwal, Curcumin, a component of turmeric: from farm to pharmacy, Biofactors 39 (2013) 2-13.
4. M. Kumaravel, P. Sankar, P. Latha, C.S. Benson, R. Rukkumani, Antiproliferative effects of an analog of curcumin in Hep-2 cells: a comparative study withcurcumin, Nat. Prod. Commun. 8 (2013) 183-186.
5. L. Masuelli, M. Benvenuto, M. Fantini, L. Marzocchella, P. Sacchetti, E. Di Stefano, I. Tresoldi, V. Izzi, R. Bernardini, C. Palumbo, M. Mattei, F. Lista, F. Galvano, A. Modesti, R. Bei, Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice, J. Biol. Regul. Homeost. Agents 27 (2013) 105-119.
6. A. Link, F. Balaguer, Y. Shen, J.J. Lozano, H.C. Leung, C.R. Boland, A. Goel, A curcumin modulates DNA methylation in colorectal cancer cells, PLoS One 8 (2013) e57709.
7. F. Peng, Q. Tao, X. Wu, H. Dou, S. Spencer, C. Mang, L. Xu, L. Sun, Y. Zhao, H. Li, S. Zeng, G. Liu, X. Hao, Cytotoxic, cytoprotective and antioxidant effects of isolated phenolic compounds from fresh ginger, Fitoterapia 3 (2012) 568-585.
8. B. Chandran, A. Goel, A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis, Phytother. Res. 26 (2012) 1719-1725.
9. S. Avasarala, F. Zhang, G. Liu, R. Wang, S.D. London, L. London, Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome, PLoS One 8 (2013) e57285.
10. K.J. Lim, S. Bisht, E.E. Bar, A. Maitra, C.G. Eberhart, A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors, Cancer Biol. Ther. 11 (2011) 464-473.
11. M. Shakibaei, A. Mobasheri, C. Lueders, F. Busch, P. Shayan, A. Goel, Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways, PLoS One 8 (2013) e57218.
12. M.X. Ye, Y.L. Zhao, Y. Li, Q. Miao, Z.K. Li, X.L. Ren, L.Q. Song, H. Yin, J. Zhang, Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms, Phytomedicine 19 (2012) 779-787.
13. Q. Tan, J. Wu, Y. Li, H. Mei, C. Zhao, J. Zhang, A supermolecular curcumin for enhanced antiproliferative and proapoptotic activities: molecular characteristics, computer modeling and in vivo pharmacokinetics, Nanotechnology 24 (2013) 035102.
14. P. Zou, L. Helson, A. Maitra, S.T. Stern, S.E. McNeil, Polymeric Curcumin Nanoparticle Pharmacokinetics and Metabolism in Bile Duct Cannulated Rats, Mol. Pharm. (2013), http://dx.doi.org/10.1021/mp4000019.
15. J. Zhang, Q. Tang, X. Xu, N. Li, Development and evaluation of a novel phytosome-loaded chitosan microsphere system forcurcumin delivery, Int. J. Pharm. 448 (2013) 168-174.
16. V. Kakkar, S.K. Muppu, K. Chopra, I.P. Kaur, Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats, Eur. J. Pharm. Biopharm. (2013)(in press, doi:pii: S0939-6411(13)00059-3).
17. P. Fadda, M. Monduzzi, F. Caboi, S. Piras, P. Lazzari, Solid lipid nanoparticle preparation by a warm microemulsion based process: Influence of microemulsion micro-structure, Int. J. Pharm. 446 (2013) 166-175.
18. P.A. Patel, S.C. Patil, D.R. Kalaria, Y.N. Kalia, V.B. Patravale, Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A, Int. J. Pharm. 446 (2013) 16-23.
19. W. Wang, R. Zhu, Q. Xie, A. Li, Y. Xiao, K. Li, H. Liu, D. Cui, Y. Chen, S. Wang, Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles, Int. J. Nanomedicine 7 (2012) 3667-3677.
20. R.R. Zhu, L.L. Qin, M. Wan, S.M. Wu, S.L. Wang, R. Zhang, Z.X. Liu, X.Y. Sun, S.D. Yao, Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles, Nanotechnology 20 (2009) 055702.
21. P.H. Killian, E. Kronski, K.M. Michalik, O. Barbieri, S. Astigiano, C.P. Sommerhoff, U. Pfeffer, A.G. Nerlich, B.E. Bachmeier, Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and-2, Carcinogenesis 3 (2012) 2507-2519.
22. B.S. Vinod, J. Antony, H.H. Nair, V.T. Puliyappadamba, M. Saikia, S.S. Narayanan, A. Bevin, R.J. Anto, Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancercells to 5-fluorouracil, Cell Death Dis. 4 (2013) e505.
23. W.D. Lu, Y. Qin, C. Yang, L. Li, Z.X. Fu, Effect of curcumin on human colon cancer mul-tidrug resistance in vitro and in vivo, Clinics (Sao Paulo) 68 (2013) 694-701.
24. S. Rahman, S. Cao, K.J. Steadman, M. Wei, H.S. Parekh, Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer, Drug Deliv. 19 (2012) 346-353.
25. A.R. Neves, M. Lucio, J.L. Lima, S. Reis, Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions, Curr. Med. Chem. 19 (2012) 1663-1681.
26. E. Vighi, M. Montanari, B. Ruozi, G. Tosi, A. Magli, E. Leo, Nuclear localization of cat-ionic solid lipid nanoparticles containing protamine as transfection promoter, Eur. J. Pharm. Biopharm. 76 (2010) 384-393.
27. W. Tiyaboonchai, W. Tungpradit, P. Plianbangchang, Formulation and characterization of curcuminoids loaded solid lipid nanoparticles, Int. J. Pharm. 337 (2007) 299-306.
28. L. Ouyang, Z. Shi, S. Zhao, F.T. Wang, T.T. Zhou, B. Liu, J.K. Bao, Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmednecrosis, Cell Prolif. 45 (2012) 487-498.
29. R. Wilken, M.S. Veena, M.B. Wang, E.S. Srivatsan, Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma, Mol. Cancer 10 (2011) 12.